RHJA
STJ

Rice Hall James & Associates’s St Jude Medical STJ Stock Holding History

Rice Hall James & Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,685
Closed -$296K – 329
2015
Q3 		$296K Hold
4,685
– – 0.02% 282
2015
Q2 		$342K Buy
+4,685
New +$338K 0.02% 284

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Rice Hall James & Associates's STJ Position: Q4 2015 in Review

Rice Hall James & Associates sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 4,685 shares — an estimated $296K sold.

Rice Hall James & Associates first reported a position in STJ in Q2 2015 and held it in 2 quarters. The position peaked at $342K in Q2 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Rice Hall James & Associates reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Rice Hall James & Associates sold 4,685 St Jude Medical shares in Q4 2015, an estimated $296K.
  • Rice Hall James & Associates first reported a position in St Jude Medical in Q2 2015 and held it in 2 quarters.
  • Rice Hall James & Associates's St Jude Medical position peaked at $342K in Q2 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.